(Q33362184)

26 July 2017

1 reference

title

Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing (English)

1 reference

heparin-induced thrombocytopenia

26 July 2017

1 reference

1 reference

1 reference

William E Dager

1

1 reference

26 July 2017

Judith Andersen

series ordinal

2

1 reference

26 July 2017

Edith Nutescu

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

26 July 2017

1 reference

26 July 2017

volume

24

1 reference

26 July 2017

issue

7 Pt 2

1 reference

26 July 2017

page(s)

88S-94S

1 reference

Heparin‐induced thrombocytopenia: pathogenesis and management

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Temporal aspects of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Heparin-induced thrombocytopenia: a ten-year retrospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Pharmacotherapy of heparin- induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Secondary prophylaxis with warfarin for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Thrombin-stimulated growth, clustering, and collagen lattice contraction of human gingival fibroblasts is associated with its protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Distribution and potential biologic function of the thrombin receptor PAR-1 on human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

Alpha-thrombin stimulates expression of macrophage migration inhibitory factor in skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.10.88S.36122

10.1592/PHCO.24.10.88S.36122

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference